Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update with no impact on study content or functionality.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.4.2. Deleted: the government funding lapse notice and the earlier Revision: v3.4.1; these are administrative changes and do not affect the study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedA funding/operational status notice was added, and the site revision tag updated to v3.4.1, replacing the previous v3.4.0 tag.SummaryDifference0.3%

- Check58 days agoChange DetectedUI changes include showing the glossary and adding a QC metadata line (Last Update Submitted that Met QC Criteria). The revision number was updated to v3.4.0 and No FEAR Act Data labeling was adjusted.SummaryDifference0.2%

- Check72 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. The study details and layout remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.